FDA inspection
GlaxoSmithKline, LLC.: FDA inspection ending Sep 28, 2007
FDA inspection 496734 · Voluntary Action Indicated (VAI) · Conshohocken, PA
Key facts
| Inspection ID | 496734 |
|---|---|
| Firm | GlaxoSmithKline, LLC. |
| FEI number | 3004055938 |
| Address | 893 River Rd Bldg 40 |
| City | Conshohocken |
| State | PA |
| ZIP | 19428-2631 |
| Fiscal year | 2007 |
| Inspection end date | Sep 28, 2007 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data